We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
-7.95%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.56B
AUM Growth
-$304M
Cap. Flow
-$67.3M
Cap. Flow %
-4.33%
Top 10 Hldgs %
82.51%
Holding
49
New
2
Increased
1
Reduced
2
Closed
4

Top Buys

Rank Stock Value
1
ARM icon
Arm
ARM
+$108M
2
NMRA icon
Neumora Therapeutics
NMRA
+$2.49M
3
DNTH icon
Dianthus Therapeutics
DNTH
+$13

Top Sells

Rank Stock Value
1
OSCR icon
Oscar Health
OSCR
+$66.9M
2
DXCM icon
DexCom
DXCM
+$62.9M
3
LYFT icon
Lyft
LYFT
+$35.5M
4
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
+$6.3M
5
HOOD icon
Robinhood
HOOD
+$6.11M

Sector Composition

Rank Sector Weight
1 Technology 54.11%
2 Healthcare 39.18%
3 Industrials 6.37%
4 Consumer Staples 0.33%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NMRA icon
26
Neumora Therapeutics
NMRA
$298M
$2.82M 0.18%
+199,608
New +$2.49M
TCRX icon
27
TScan Therapeutics
TCRX
$48.6M
$2.76M 0.18%
1,077,080
– –
FHTX icon
28
Foghorn Therapeutics
FHTX
$266M
$2.5M 0.16%
500,901
– –
TNYA icon
29
Tenaya Therapeutics
TNYA
$161M
$2.34M 0.15%
915,705
– –
TSHA icon
30
Taysha Gene Therapies
TSHA
$1.68B
$2.03M 0.13%
640,882
– –
KRON
31
DELISTED
Kronos Bio
KRON
$1.87M 0.12%
1,438,232
– –
HYPR icon
32
Hyperfine
HYPR
$92.9M
$1.84M 0.12%
898,720
– –
AUTL
33
Autolus Therapeutics
AUTL
$397M
$1.63M 0.1%
698,262
– –
EXAS
34
DELISTED
Exact Sciences
EXAS
$1.58M 0.1%
23,205
– –
SNCE
35
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$1.28M 0.08%
160,363
– –
ALEC icon
36
Alector
ALEC
$168M
$1.14M 0.07%
175,866
– –
SPRO icon
37
Spero Therapeutics
SPRO
$67.7M
$1.08M 0.07%
889,979
– –
RANI icon
38
Rani Therapeutics
RANI
$87M
$973K 0.06%
448,492
– –
QNCX icon
39
Quince Therapeutics
QNCX
$22.9M
$212K 0.01%
946
– –
EVLO
40
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$208K 0.01%
53,024
– –
NVTA
41
DELISTED
Invitae Corporation
NVTA
$144K 0.01%
235,606
– –
MOND
42
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$65.8K ﹤0.01%
18,420
– –
FULC icon
43
Fulcrum Therapeutics
FULC
$273M
$63.3K ﹤0.01%
14,262
– –
RGEN icon
44
Repligen
RGEN
$7.96B
$60.9K ﹤0.01%
383
– –
HLTH
45
DELISTED
Cue Health Inc. Common Stock
HLTH
$11.9K ﹤0.01%
27,000
– –
HOOD icon
46
Robinhood
HOOD
$77.8B
– –
-612,214
Closed -$6.11M
LYFT icon
47
Lyft
LYFT
$6.02B
– –
-3,702,054
Closed -$35.5M
OPRT icon
48
Oportun Financial
OPRT
$255M
– –
-94,788
Closed -$566K
DBTX
49
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
– –
-1,636,258
Closed -$6.3M
1
2

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q3 2023 Portfolio in Review

As of Q3 2023, Alphabet Inc held 49 positions worth $1.56B, down 16% from $1.86B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Alphabet Inc withdrew a net $67.3M in Q3 2023, closing 4 positions and reducing 2 holdings. Its most notable exit was Lyft, an estimated $35.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 41% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alphabet Inc opened a new position in Arm worth $105M.

  • Alphabet Inc's largest Q3 2023 buy was Arm: 1,960,784 shares worth $105M.
  • Alphabet Inc added most to Dianthus Therapeutics in Q3 2023, an estimated $13 increase.
  • Alphabet Inc's biggest Q3 2023 reduction was Oscar Health, cutting an estimated $66.9M.
  • Alphabet Inc fully exited Lyft in Q3 2023, selling an estimated $35.5M.
  • Alphabet Inc's ten largest holdings make up 83% of its $1.56B portfolio in Q3 2023.
  • Alphabet Inc opened 2 new positions and closed 4 in Q3 2023.
  • Alphabet Inc's portfolio value fell 16% quarter-over-quarter to $1.56B.

Based on Alphabet Inc's 13F filing for Q3 2023, filed 13 Nov 2023.